Strs Ohio Arrowhead Pharmaceuticals, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$21.87 - $28.24 $56,862 - $73,424	-2,600 Reduced 10.12%	23,100 $600,000
Q1 2024 May 13, 2024	SELL	$27.21 - $39.48 $76,188 - $110,543	-2,800 Reduced 9.82%	25,700 $735,000
Q4 2023 Jan 30, 2024	BUY	$21.2 - $31.03 $40,280 - $58,957	1,900 Added 7.14%	28,500 $872,000
Q2 2023 Jul 31, 2023	BUY	$25.16 - $41.38 $10,064 - $16,552	400 Added 1.53%	26,600 $948,000
Q1 2023 Aug 02, 2023	SELL	$23.68 - $38.51 $9,472 - $15,404	-400 Reduced 1.5%	26,200 $665,000
Q1 2023 Apr 27, 2023	SELL	$23.68 - $38.51 $187,072 - $304,229	-7,900 Reduced 23.17%	26,200 $665,000
Q3 2022 Oct 27, 2022	SELL	$29.63 - $48.31 $195,558 - $318,846	-6,600 Reduced 16.22%	34,100 $1.13 Million
Q2 2022 Jul 25, 2022	BUY	$27.79 - $50.61 $33,348 - $60,732	1,200 Added 3.04%	40,700 $1.43 Million
Q1 2022 Apr 21, 2022	BUY	$39.62 - $69.97 $245,643 - $433,814	6,200 Added 18.62%	39,500 $1.82 Million
Q4 2021 Jan 24, 2022	BUY	$58.09 - $82.51 $116,180 - $165,020	2,000 Added 6.39%	33,300 $2.21 Million
Q3 2021 Oct 22, 2021	SELL	$58.38 - $84.96 $11,676 - $16,992	-200 Reduced 0.63%	31,300 $1.95 Million
Q2 2021 Jul 26, 2021	BUY	$62.15 - $90.32 $285,890 - $415,471	4,600 Added 17.1%	31,500 $2.61 Million
Q1 2021 Apr 23, 2021	BUY	$61.35 - $90.47 $79,755 - $117,611	1,300 Added 5.08%	26,900 $1.78 Million
Q4 2020 Jan 25, 2021	BUY	$43.82 - $85.37 $144,606 - $281,721	3,300 Added 14.8%	25,600 $1.96 Million
Q3 2020 Dec 14, 2020	SELL	$33.21 - $51.27 $342,063 - $528,081	-10,300 Reduced 31.6%	22,300 $960,000
Q2 2020 Jul 23, 2020	SELL	$26.12 - $43.27 $120,152 - $199,042	-4,600 Reduced 12.37%	32,600 $1.41 Million
Q1 2020 Apr 23, 2020	BUY	$20.56 - $63.12 $96,632 - $296,664	4,700 Added 14.46%	37,200 $1.07 Million
Q4 2019 Jan 24, 2020	SELL	$28.14 - $73.01 $284,214 - $737,401	-10,100 Reduced 23.71%	32,500 $2.06 Million
Q3 2019 Oct 21, 2019	BUY	$26.26 - $34.86 $425,412 - $564,732	16,200 Added 61.36%	42,600 $1.2 Million
Q2 2019 Jul 25, 2019	BUY	$17.43 - $28.82 $240,534 - $397,716	13,800 Added 109.52%	26,400 $699,000
Q1 2019 Apr 19, 2019	BUY	$12.05 - $20.18 $151,830 - $254,268	12,600 New	12,600 $231,000

Others Institutions Holding ARWR

# of Institutions

294

Shares Held

90.8M

Call Options Held

155K

Put Options Held

426K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.08B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account